FACI is a novel clathrin adaptor protein 2-binding protein that facilitates low-density lipoprotein endocytosis
© 2023. The Author(s)..
BACKGROUND: Cholesterol plays a vital role in multiple physiological processes. Cellular uptake of cholesterol is mediated primarily through endocytosis of low-density lipoprotein (LDL) receptor. New modifiers of this process remain to be characterized. Particularly, the role of fasting- and CREB-H-induced (FACI) protein in cholesterol homeostasis merits further investigation.
METHODS: Interactome profiling by proximity labeling and affinity purification - mass spectrometry was performed. Total internal reflection fluorescence microscopy and confocal immunofluorescence microscopy were used to analyze protein co-localization and interaction. Mutational analysis was carried out to define the domain and residues required for FACI localization and function. Endocytosis was traced by fluorescent cargos. LDL uptake in cultured cells and diet-induced hypercholesterolemia in mice were assessed.
RESULTS: FACI interacted with proteins critically involved in clathrin-mediated endocytosis, vesicle trafficking, and membrane cytoskeleton. FACI localized to clathrin-coated pits (CCP) on plasma membranes. FACI contains a conserved DxxxLI motif, which mediates its binding with the adaptor protein 2 (AP2) complex. Disruption of this motif of FACI abolished its CCP localization but didn't affect its association with plasma membrane. Cholesterol was found to facilitate FACI transport from plasma membrane to endocytic recycling compartment in a clathrin- and cytoskeleton-dependent manner. LDL endocytosis was enhanced in FACI-overexpressed AML12 cells but impaired in FACI-depleted HeLa cells. In vivo study indicated that hepatic FACI overexpression alleviated diet-induced hypercholesterolemia in mice.
CONCLUSIONS: FACI facilitates LDL endocytosis through its interaction with the AP2 complex.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Cell & bioscience - 13(2023), 1 vom: 18. Apr., Seite 74 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cheng, Yun [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cholesterol uptake |
|---|
| Anmerkungen: |
Date Revised 21.04.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1186/s13578-023-01023-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM355767422 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM355767422 | ||
| 003 | DE-627 | ||
| 005 | 20231226065035.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13578-023-01023-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1185.xml |
| 035 | |a (DE-627)NLM355767422 | ||
| 035 | |a (NLM)37072871 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cheng, Yun |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a FACI is a novel clathrin adaptor protein 2-binding protein that facilitates low-density lipoprotein endocytosis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 21.04.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a BACKGROUND: Cholesterol plays a vital role in multiple physiological processes. Cellular uptake of cholesterol is mediated primarily through endocytosis of low-density lipoprotein (LDL) receptor. New modifiers of this process remain to be characterized. Particularly, the role of fasting- and CREB-H-induced (FACI) protein in cholesterol homeostasis merits further investigation | ||
| 520 | |a METHODS: Interactome profiling by proximity labeling and affinity purification - mass spectrometry was performed. Total internal reflection fluorescence microscopy and confocal immunofluorescence microscopy were used to analyze protein co-localization and interaction. Mutational analysis was carried out to define the domain and residues required for FACI localization and function. Endocytosis was traced by fluorescent cargos. LDL uptake in cultured cells and diet-induced hypercholesterolemia in mice were assessed | ||
| 520 | |a RESULTS: FACI interacted with proteins critically involved in clathrin-mediated endocytosis, vesicle trafficking, and membrane cytoskeleton. FACI localized to clathrin-coated pits (CCP) on plasma membranes. FACI contains a conserved DxxxLI motif, which mediates its binding with the adaptor protein 2 (AP2) complex. Disruption of this motif of FACI abolished its CCP localization but didn't affect its association with plasma membrane. Cholesterol was found to facilitate FACI transport from plasma membrane to endocytic recycling compartment in a clathrin- and cytoskeleton-dependent manner. LDL endocytosis was enhanced in FACI-overexpressed AML12 cells but impaired in FACI-depleted HeLa cells. In vivo study indicated that hepatic FACI overexpression alleviated diet-induced hypercholesterolemia in mice | ||
| 520 | |a CONCLUSIONS: FACI facilitates LDL endocytosis through its interaction with the AP2 complex | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cholesterol uptake | |
| 650 | 4 | |a Clathrin adaptors | |
| 650 | 4 | |a Endocytosis | |
| 650 | 4 | |a FACI | |
| 650 | 4 | |a Hypercholesterolemia | |
| 650 | 4 | |a Low-density lipoprotein receptor | |
| 700 | 1 | |a Kang, Xiao-Zhuo |e verfasserin |4 aut | |
| 700 | 1 | |a Chan, Pearl |e verfasserin |4 aut | |
| 700 | 1 | |a Cheung, Pak-Hin Hinson |e verfasserin |4 aut | |
| 700 | 1 | |a Cheng, Tao |e verfasserin |4 aut | |
| 700 | 1 | |a Ye, Zi-Wei |e verfasserin |4 aut | |
| 700 | 1 | |a Chan, Chi-Ping |e verfasserin |4 aut | |
| 700 | 1 | |a Yu, Cheng-Han |e verfasserin |4 aut | |
| 700 | 1 | |a Jin, Dong-Yan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell & bioscience |d 2011 |g 13(2023), 1 vom: 18. Apr., Seite 74 |w (DE-627)NLM209533447 |x 2045-3701 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2023 |g number:1 |g day:18 |g month:04 |g pages:74 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13578-023-01023-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2023 |e 1 |b 18 |c 04 |h 74 | ||